Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Investigation of Newly Developed Ostomy Products in Subjects With Ileostomy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01994902
Recruitment Status : Completed
First Posted : November 26, 2013
Results First Posted : January 12, 2016
Last Update Posted : January 12, 2016
Sponsor:
Information provided by (Responsible Party):
Coloplast A/S

Brief Summary:
The aim of the investigation was to investigate the performance and safety of a new ostomy product.

Condition or disease Intervention/treatment Phase
Stoma Ileostomy Device: Coloplast test product Device: SenSura Convex Light Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 129 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Investigation of Newly Developed 1-and 2-piece Convex Ostomy Products in Subjects With Ileostomy.
Study Start Date : November 2013
Actual Primary Completion Date : June 2014
Actual Study Completion Date : June 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Ostomy

Arm Intervention/treatment
Experimental: First Coloplast test product

The subjects test:

test period 1: Coloplast test product test period 2: SenSura Convex Light

Device: Coloplast test product
The Coloplast test product is a newly developed ostomy appliance

Device: SenSura Convex Light
The comparator product is SenSura Convex Light, which is CE-marked and commercially available.
Other Name: SenSura

Experimental: First SenSura Convex Light

The subjects test:

test period 1: SenSura Convex Light test period 2: Coloplast test product

Device: Coloplast test product
The Coloplast test product is a newly developed ostomy appliance

Device: SenSura Convex Light
The comparator product is SenSura Convex Light, which is CE-marked and commercially available.
Other Name: SenSura




Primary Outcome Measures :
  1. Degree of Leakage [ Time Frame: 28 +/- 3 days ]
    The degree of leakage is measured using a 33-point scale measuring leakage under the baseplate, where 0 points represents the best possible outcome (no leakage) and 33 points the worst possible outcome (leakage on the whole baseplate).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Are at least 18 years of age and have full legal capacity.
  2. Has had an ileostomy for at least 3 months.
  3. Has used a convex ostomy product for the last month.
  4. Has given signed informed consent.
  5. Has experienced seeping under the baseplate at least three times during the last two weeks.
  6. Currently using a SenSura Convex product with midi, maxi or magnum bags.
  7. Currently using a 1-piece product or a 2-piece product with a mechanical coupling ("click coupling").
  8. Has an ileostomy with a diameter of max 33 mm (1-piece product) or less. Or Has an ileostomy with a diameter of 30 mm (2-piece product) or less.

Exclusion Criteria:

  1. Has a loop-ostomy (double-barrel ostomy or ostomy with two outlets).
  2. Are pregnant or breastfeeding.
  3. Currently receiving, or has within the past 2 months received radio- and/or chemotherapy.
  4. Currently receiving, or has within the past month received steroid treatment (adrenocortical hormone) systemically or locally in the peristomal area.
  5. Currently suffering from peristomal skin problems i.e. bleeding or broken (weeping) skin.
  6. Are currently participating in another clinical intervention study or have previously participated in this one.
  7. Has a fistula in the peristomal area or less than 2 cm from the edge of the baseplate.
  8. Has known hypersensitivity toward the test product.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01994902


Locations
Show Show 29 study locations
Sponsors and Collaborators
Coloplast A/S
Investigators
Layout table for investigator information
Study Director: Daniel Carter Coloplast A/S
Layout table for additonal information
Responsible Party: Coloplast A/S
ClinicalTrials.gov Identifier: NCT01994902    
Other Study ID Numbers: CP232
First Posted: November 26, 2013    Key Record Dates
Results First Posted: January 12, 2016
Last Update Posted: January 12, 2016
Last Verified: December 2015